HK Stock Market Move | HEALTHYWAY INC (02587) surged over 20% during trading as it strategically reallocates IPO funds to increase investment in AI technology, with a clear and verifiable commercialization path.

HEALTHYWAY INC (02587) surged significantly this morning, with an intra-day high increase of over 20%, reaching a peak of HKD 2.56. As of the time of publication, it was up 8.45% at HKD 2.31, with a transaction volume of HKD 150 million. On the news front, at the end of last month, HEALTHYWAY INC released a supplement announcement regarding the strategic reallocation of approximately HKD 107 million in unutilized IPO funds. The funds originally planned for expanding physical pharmacies and large-scale recruitment of on-site health assistants and business representatives will now be fully redirected towards the research and development of AI intelligent agent technology and regional ecological layout. Notably, this ramp-up in AI is not mere concept hype; the company's related business has already achieved continuous implementation, with a clear and verifiable commercialization path. In 2025, the first year of the AI intelligent agent's launch, it is expected to generate over HKD 32 million in revenue. In March this year, the company secured digitalization projects with Sichuan Provincial Orthopedic Hospital and Anji County People's Hospital. In June, it won the bidding for the Rizhao mobile computing power grid project. On July 20, HEALTHYWAY INC signed an agreement with Xi'an Health Medical Group to co-build AI smart communities, planning to cover the first batch of 30 grassroots medical institutions in Xi'an. This marks a transition for the company's AI solutions from pilot projects to standardized large-scale delivery.